Literature DB >> 7691346

Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele.

H Hofmann-Radvanyi1, C Lavedan, J P Rabès, D Savoy, C Duros, K Johnson, C Junien.   

Abstract

Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease. The mutation has been identified as an unstable trinucleotide CTG repeat in a sequence encoding a putative cAMP-dependent protein kinase. The CTG repeat varies in length between affected siblings, and generally increases through generations in parallel with increasing severity of the disease. Congenital myotonic dystrophy, which represents the most severe phenotype, is exclusively maternally inherited. In this report, we show, by Northern blot analysis, that no mutated enlarged transcript is detectable in a 20-week-old DM fetus and in two congenitally affected infants. Furthermore, in skeletal and cardiac muscle of the DM fetus, we observed by RNA analysis, including Northern blot and RT-PCR, an unexpectedly low expression of the paternal wild type allele. Varying degrees of expression of the mutant and/or the normal allele might therefore account for the characteristic features of the congenital form and the extreme variability of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691346     DOI: 10.1093/hmg/2.8.1263

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes.

Authors:  M G Hamshere; E E Newman; M Alwazzan; B S Athwal; J D Brook
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.

Authors:  P Steinbach; D Gläser; W Vogel; M Wolf; S Schwemmle
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

Authors:  C Abbruzzese; R Krahe; M Liguori; D Tessarolo; M J Siciliano; T Ashizawa; M Giacanelli
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

4.  Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells.

Authors:  A A Benders; P J Groenen; F T Oerlemans; J H Veerkamp; B Wieringa
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 5.  Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive.

Authors:  P N Strong; B S Brewster
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 6.  The molecular basis of genetic dominance.

Authors:  A O Wilkie
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

Review 7.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

8.  Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat.

Authors:  A Jaspert; R Fahsold; H Grehl; D Claus
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

Review 9.  RNA-mediated toxicity in neurodegenerative disease.

Authors:  Veronique V Belzil; Tania F Gendron; Leonard Petrucelli
Journal:  Mol Cell Neurosci       Date:  2012-12-29       Impact factor: 4.314

10.  Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.

Authors:  Beatriz Llamusí; Ruben Artero
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.